(Q36319341)

13 August 2017

1 reference

title

Review: intravenous immunoglobulin therapy and thromboembolic complications (English)

1 reference

13 August 2017

1 reference

2

Y Shoenfeld

1 reference

13 August 2017

1

U Katz

1 reference

13 August 2017

language of work or name

1 reference

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

14

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

802-808

1 reference

Intravenous immune globulins: an update for clinicians

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Intravenous immunoglobulins and transforming growth factor beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

High-dose intravenous immunoglobulins for lupus nephritis--a salvage immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Intravenous immunoglobulin and the kidney--a two-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

i.v.IG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Therapy with Intravenous Immunoglobulins: Complications and Side-Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Thromboembolic complications of intravenous immunoglobulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Complications of intravenous immune globulin treatment in neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Thrombotic complications after intravenous immunoglobulin therapy in two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

Transverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203303LU2168RR

10.1191/0961203303LU2168RR

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference